These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2554500)

  • 1. Strategy for the development of the low molecular weight heparin fraction CY 216 in the prevention of postoperative deep vein thromboses in general surgery.
    Toulemonde F
    Semin Thromb Hemost; 1989 Oct; 15(4):395-400. PubMed ID: 2554500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory control of heparin and heparin fragment treatment: an experimental study.
    Doutremepuich C; Lalanne MC; Guyot M; Doutremepuich F; De Sèze O; Toulemonde F
    Semin Thromb Hemost; 1989 Oct; 15(4):373-7. PubMed ID: 2554497
    [No Abstract]   [Full Text] [Related]  

  • 3. Low molecular weight heparin: laboratory properties and clinical evaluation. A review.
    Hirsh J; Levine MN
    Eur J Surg Suppl; 1994; (571):9-22. PubMed ID: 7519092
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

  • 5. Potentiation by heparin fragment CY 222 (Choay) of thrombolysis induced by human tissue-type plasminogen activator.
    Juhan-Vague I; Stassen JM; Alessi MC; Elias A; Aillaud MF; Serradimigni A; Collen D
    Semin Thromb Hemost; 1989 Oct; 15(4):390-4. PubMed ID: 2554499
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of deep venous thrombosis by a new low molecular weight heparin (Fluxum) in cardiac surgery.
    Beghi C; Fragnito C; Antonelli A; Reverberi C; Ferrari P; Saccani S; Fesani F
    Int Angiol; 1993 Dec; 12(4):383-6. PubMed ID: 8207317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].
    Faivre R; Neuhart E; Kieffer Y; Bassand JP; Maurat JP
    J Mal Vasc; 1987; 12 Suppl B():145-6. PubMed ID: 2834488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.
    Bergqvist D
    Br J Surg; 1998 Jun; 85(6):872. PubMed ID: 9667723
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
    Hirsh J
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of the low molecular weight heparin fraction CY 216 in the prevention of postoperative thrombosis in general surgery].
    Toulemonde F
    Therapie; 1988 May; 43(3):187-92. PubMed ID: 2844004
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of thrombosis in gynecology: double-blind comparison of low molecular weight heparin and unfractionated heparin].
    Heilmann L; Kruck M; Schindler AE
    Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):803-7. PubMed ID: 2553528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of postoperative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY 216).
    Marassi A; Balzano G; Mari G; D'Angelo SV; Della Valle P; Di Carlo V; D'Angelo A
    Int Surg; 1993; 78(2):166-70. PubMed ID: 8394842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of postoperative deep vein thrombosis by two different heparin types.
    Catania G; Salanitri G
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):304-9. PubMed ID: 2842266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of thromboembolic disease in general surgery with enoxaparin (Clexane).
    Samama M; Combe S
    Acta Chir Scand Suppl; 1990; 556():91-5. PubMed ID: 1963022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of complications of major orthopedic surgery: comparison of indobufen, calcium heparin, and low molecular heparin].
    Borghi B; Bassi A; Grazia M; Feoli MA; Pignotti E
    Minerva Anestesiol; 1996 Mar; 62(3):93-100. PubMed ID: 8767154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin prevention of post-operative deep vein thrombosis in vascular surgery.
    Speziale F; Verardi S; Taurino M; Nicolini G; Rizzo L; Fiorani P; Palazzini E
    Pharmatherapeutica; 1988; 5(4):261-8. PubMed ID: 3174726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bemiparin: second-generation, low-molecular-weight heparin for treatment and prophylaxis of venous thromboembolism.
    Martínez-González J; Vila L; Rodríguez C
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):793-802. PubMed ID: 18570617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between ex vivo anti-factor Xa levels and efficacy/safety of low molecular weight heparin.
    Turpie AG
    Br J Clin Pract Suppl; 1989 Jan; 65():18-23; discussion 23-5. PubMed ID: 2554949
    [No Abstract]   [Full Text] [Related]  

  • 19. An objective evaluation of the clinical potential of low molecular weight heparins in the prevention of thromboembolism.
    Haas S; Blümel G
    Semin Thromb Hemost; 1989 Oct; 15(4):424-34. PubMed ID: 2554503
    [No Abstract]   [Full Text] [Related]  

  • 20. Low molecular weight heparin (Alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures.
    Pini M; Tagliaferri A; Manotti C; Lasagni F; Rinaldi E; Dettori AG
    Int Angiol; 1989; 8(3):134-9. PubMed ID: 2556484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.